MedPath
Found 2 clinical trials|View Analysis
Sort by:

A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease

Phase 2
Recruiting
Conditions
Mild Alzheimer Disease
Interventions
Drug: PM012
Drug: PM012 Placebo
Drug: Donepezil
Drug: Donepezil placebo
First Posted Date
2023-04-13
Last Posted Date
2023-04-18
Lead Sponsor
Mediforum Ltd., Co.
Target Recruit Count
312
Registration Number
NCT05811000
Locations
🇰🇷

Mediforum, Seoul, Seongdon-gu, Korea, Republic of

Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: PM012
Drug: Placebo
First Posted Date
2012-10-26
Last Posted Date
2016-04-18
Lead Sponsor
VTBIO Co. LTD
Target Recruit Count
151
Registration Number
NCT01715350
Locations
🇰🇷

Kyung Hee University Oriental Medicine Hospital, Seoul, Dongdaemun-gu, Korea, Republic of

🇰🇷

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Seocho-gu, Korea, Republic of

🇰🇷

National Health Insurance Corporation Ilsan Hospital, Goyang, Ilsandong-gu, Korea, Republic of

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath